A Phase II Trial of Postoperative Proton Radiotherapy With Concomitant Chemotherapy for Patients With Resected Pancreatic Adenocarcinoma
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Gemcitabine (Primary)
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- Acronyms PC03
- 01 Sep 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 17 Nov 2016 Status changed from recruiting to active, no longer recruiting.